financetom
Business
financetom
/
Business
/
Exro Gets Shareholder Approval For Proposed Merger With SEA Electric; Deal Expected To Be Completed By Late Tomorrow
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exro Gets Shareholder Approval For Proposed Merger With SEA Electric; Deal Expected To Be Completed By Late Tomorrow
Apr 4, 2024 12:38 PM

03:20 PM EDT, 04/04/2024 (MT Newswires) -- Exro Technologies Inc. ( EXROF ) announced Thursday that all necessary shareholder and stockholder approvals required in connection with the proposed merger with SEA Electric Inc. have been obtained.

According to a statement, the transaction is expected to be completed on or about April 5, 2024 and is subject to the satisfaction of all closing conditions set out in the merger agreement.

Exro Technologies Inc. ( EXROF ) is a clean technology company that has developed new generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries.

Price: 0.82, Change: -0.05, Percent Change: -5.78

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders
May 13, 2024
09:34 AM EDT, 05/13/2024 (MT Newswires) -- AbbVie ( ABBV ) and Gilgamesh Pharmaceuticals said Monday that they have entered into an option-to-license agreement to develop neuroplastogens to treat psychiatric disorders. Development and commercialization activities will be led by AbbVie ( ABBV ) upon exercise of the option, according to the companies. Gilgamesh will get $65 million in upfront payment...
Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program
Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program
May 13, 2024
09:31 AM EDT, 05/13/2024 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) said Monday that it has signed an accelerated share repurchase agreement with investment bank Jefferies to buy back $35 million of its common stock. Collegium said it will execute the deal as part of a $150 million share repurchase program the board authorized in January. Following the completion...
Update: Blackstone to Take Japan's I'rom Private at 50% Premium
Update: Blackstone to Take Japan's I'rom Private at 50% Premium
May 13, 2024
09:32 AM EDT, 05/13/2024 (MT Newswires) -- (Updates with additional information) Blackstone (BX) said Monday its private equity funds and vehicles have entered a definitive agreement with the management of Japanese pharmaceutical services company I'rom Group to take it private. The asset management firm will offer to acquire I'rom shares at 2,800 yen ($17.96) per share -- about a 50%...
Permian Resources Shareholders Launch Public Offering of 51.8 Million Class A Shares
Permian Resources Shareholders Launch Public Offering of 51.8 Million Class A Shares
May 13, 2024
09:31 AM EDT, 05/13/2024 (MT Newswires) -- Permian Resources ( PR ) said Monday that certain shareholders had launched a public offering of about 51.8 million of its Class A shares. The company said the sellers include certain affiliates of EnCap Investments, NGP Energy Capital Management, Pearl Energy Investments, Riverstone Investment Group, and a member of Permian's board. The oil...
Copyright 2023-2026 - www.financetom.com All Rights Reserved